Document is current
Any future updates will be listed below
-
Authors
Bolderson, Emma http://orcid.org/0000-0002-2849-1177
Burgess, Joshua T.
Li, Jun
Gandhi, Neha S. http://orcid.org/0000-0003-3119-6731
Boucher, Didier
Croft, Laura V.
Beard, Samuel
Plowman, Jennifer J.
Suraweera, Amila http://orcid.org/0000-0002-1079-2887
Adams, Mark N. http://orcid.org/0000-0003-1906-5018
Naqi, Ali
Zhang, Shu-Dong http://orcid.org/0000-0002-7721-0167
Sinclair, David A.
O’Byrne, Kenneth J.
Richard, Derek J.
-
Funding
Funding for this research was provided by:
State of Queensland | Advance Queensland (N/A)
- License Information
-
More Information
Article History
Received: 19 December 2018
Accepted: 22 October 2019
First Online: 3 December 2019
Competing interests
: K.J.O. and D.J.R. are founders of CARP Pharmaceuticals. E.B, D.J.R and K.J.O. are founders of Carpe Vitae Pharmaceuticals. E.B., J.T.B, K.J.O. and D.J.R. are inventors on provisional patent applications filed by Queensland University of Technology. D.A.S is a founder, equity owner, advisor, director, consultant, investor and/or inventor on patents licensed to Vium, Jupiter Orphan Therapeutics, Cohbar, Galilei Biosciences, Wellomics, EdenRoc Sciences (affiliates Arc-Bio, Dovetail Genomics, Claret, Revere, UpRNA, MetroBiotech, Liberty) and Life Biosciences (affiliates Selphagy, Senolytic Therapeutics, Spotlight Therapeutics, Immetas, Animal Biosciences, Iduna, Continuum, Jumpstart). He is an inventor on a patent application filed by Harvard Medical School licensed to Elysium Health. See ExternalRef removed. All other authors declare no competing interests.
